208 related articles for article (PubMed ID: 34143243)
1. Sleep behavior of infants with infantile hemangioma treated with propranolol-a cohort study.
Theiler M; Knöpfel N; von der Heydt S; Schwieger-Briel A; Luchsinger I; Smith A; Kernland-Lang K; Waelchli R; Neuhaus K; Kohler M; Gnannt R; Schoch SF; Weibel L; Kurth S
Eur J Pediatr; 2021 Aug; 180(8):2655-2668. PubMed ID: 34143243
[TBL] [Abstract][Full Text] [Related]
2. Propranolol's effects on the sleep of infants with hemangiomas: A prospective pilot study.
Frost S; Saddi V; Teng A; Mallitt KA; Adams S; Williamson B; Wargon O
Pediatr Dermatol; 2021 Mar; 38(2):371-377. PubMed ID: 33351238
[TBL] [Abstract][Full Text] [Related]
3. Preliminary results of propranolol treatment for patients with infantile hemangioma.
Corapcioğlu F; Büyükkapu-Bay S; Binnetoğlu K; Babaoğlu A; Anik Y; Tugay M
Turk J Pediatr; 2011; 53(2):137-41. PubMed ID: 21853649
[TBL] [Abstract][Full Text] [Related]
4. Effects of systemic propranolol treatment on physical growth of patients with infantile hemangiomas.
Hu L; Zhou B; Huang H; Chang L; Qiu Y; Ma G; Chen H; Jin Y; Xu X; Lin X; Li W
J Dermatol; 2016 Oct; 43(10):1160-1166. PubMed ID: 26945921
[TBL] [Abstract][Full Text] [Related]
5. Propranolol for infantile hemangiomas.
Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
[TBL] [Abstract][Full Text] [Related]
6. Recurrence rate of infantile hemangioma after oral propranolol therapy.
Frongia G; Byeon JO; Mehrabi A; Günther P
Eur J Pediatr; 2021 Feb; 180(2):585-590. PubMed ID: 33188478
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes of Infants With Periorbital Hemangiomas Treated With Oral Propranolol.
Xue L; Sun C; Xu DP; Liu ZM; Wang XK
J Oral Maxillofac Surg; 2016 Nov; 74(11):2193-2199. PubMed ID: 27235180
[TBL] [Abstract][Full Text] [Related]
8. Propranolol treatment of infantile hemangioma (IH) is not associated with developmental risk or growth impairment at age 4 years.
Moyakine AV; Kerstjens JM; Spillekom-van Koulil S; van der Vleuten CJ
J Am Acad Dermatol; 2016 Jul; 75(1):59-63.e1. PubMed ID: 27021240
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and blood glucose parameters in infants during propranolol initiation for treatment of symptomatic infantile hemangiomas.
Puttgen KB; Summerer B; Schneider J; Cohen BA; Boss EF; Bauman NM
Ann Otol Rhinol Laryngol; 2013 Sep; 122(9):550-4. PubMed ID: 24224397
[TBL] [Abstract][Full Text] [Related]
10. Treatment of infantile hemangiomas with propranolol: clinical guidelines.
Szychta P; Stewart K; Anderson W
Plast Reconstr Surg; 2014 Apr; 133(4):852-862. PubMed ID: 24352207
[TBL] [Abstract][Full Text] [Related]
11. Prolonged growth of infantile hemangioma after pulsed dye laser and oral propranolol treatment.
Kagami S; Kaneko M; Kishi A; Katori T
J Dermatol; 2018 Sep; 45(9):1109-1112. PubMed ID: 29952019
[TBL] [Abstract][Full Text] [Related]
12. [Infantile hemangiomas: the revolution of beta-blockers].
Leaute-Labreze C
Rev Prat; 2014 Dec; 64(10):1421-8. PubMed ID: 25665327
[TBL] [Abstract][Full Text] [Related]
13. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants.
de Graaf M; Breur JMPJ; Raphaël MF; Vos M; Breugem CC; Pasmans SGMA
J Am Acad Dermatol; 2011 Aug; 65(2):320-327. PubMed ID: 21601311
[TBL] [Abstract][Full Text] [Related]
14. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants.
Erbay A; Sarialioglu F; Malbora B; Yildirim SV; Varan B; Tarcan A; Gülcan H; Demir S; Derbent M; Uslu N; Abbasoğlu A
Turk J Pediatr; 2010; 52(5):450-6. PubMed ID: 21434528
[TBL] [Abstract][Full Text] [Related]
15. Effects of propranolol therapy in Moroccan children with infantile hemangioma.
Lahrichi A; Hali F; Baline K; Fatoiki FZE; Chiheb S; Khadir K
Arch Pediatr; 2018 Nov; 25(8):449-451. PubMed ID: 30361087
[TBL] [Abstract][Full Text] [Related]
16. Oral Nadolol for Children with Infantile Hemangiomas and Sleep Disturbances with Oral Propranolol.
Bernabeu-Wittel J; Narváez-Moreno B; de la Torre-García JM; Fernández-Pineda I; Domínguez-Cruz JJ; Coserría-Sánchez F; Álvarez-del-Vayo C; Conejo-Mir J
Pediatr Dermatol; 2015; 32(6):853-7. PubMed ID: 26447831
[TBL] [Abstract][Full Text] [Related]
17. The use of propranolol for complicated infantile hemangiomas.
Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma.
Aly MM; Hamza AF; Abdel Kader HM; Saafan HA; Ghazy MS; Ragab IA
Eur J Pediatr; 2015 Nov; 174(11):1503-9. PubMed ID: 25982338
[TBL] [Abstract][Full Text] [Related]
19. Beta Blockade as Treatment for Intracranial Infantile Hemangioma: Case Report and Literature Review.
Kang E; Friedman N; Mamoun I; Tamburro J; Golden A
Pediatr Neurol; 2016 Jun; 59():13-7. PubMed ID: 27068061
[TBL] [Abstract][Full Text] [Related]
20. Infantile hemangiomas: what have we learned from propranolol?
Hagen R; Ghareeb E; Jalali O; Zinn Z
Curr Opin Pediatr; 2018 Aug; 30(4):499-504. PubMed ID: 29846253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
